|
|
|
 |
FDA Approval Activities for this Drug…
Lariam (mefloquine hydrochloride) Tablets, 250 mg Hoffman-LaRoche, NDA 19-591/S-022 8/20/03 8/28/03 8/28/03 | Lariam (mefloquine hydrochloride) Tablets, 250 mg Hoffman-LaRoche, NDA 19-591/S-020 10/3/02 10/4/02 | Lariam (mefloquine hydrochloride) Tablets, 250 mg Hoffman-LaRoche, NDA 19-591/S-019 7/9/03 7/10/03 7/9/03 | Lariam (mefloquine hydrochloride) Tablets, 250 mg Hoffman-LaRoche, NDA 19-591/S-14/17 Mefloquine Hydrochloride Tablets, 250 mg, Roxane ANDA 76-523 9/12/03 | Mefloquine Hydrochloride Tablets, 250 mg, Geneva Pharamaceuticals ANDA 76-175 MEFLOQUINE HYDROCHLORIDE Tablet; 250MG MEFLOQUINE HCL Geneva | 019591 MEFLOQUINE HYDROCHLORIDE Tablet; 250MG LARIAM ROCHE Mefloquine Hydrochloride Tablets, Barr Laboratories | Mefloquine Hydrochloride Tablets, Roxane Labs, Approval | Lariam (mefloquine hydrochloride) Tablets, Hoffmann-La Roche, Inc., Labeling Revision | Lariam (mefloquine hydrochloride) Tablets, Hoffmann-La Roche, Labeling Revision | Lariam (mefloquine hydrochloride) Tablets, Hoffmann-La Roche Inc., Labeling Revision | Mefloquine Hydrochloride Tablets, West-Ward Pharmaceutical Corp., Approval | Lariam (mefloquine hydrochloride) Tablets, Hoffmann-La Roche Inc., Supplement
  
|